-
1
-
-
0036199654
-
Cancer/testis antigens: Structural and immunobiological properties
-
Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. Cancer/testis antigens: structural and immunobiological properties. Cancer Invest 2002; 20: 222-36.
-
(2002)
Cancer Invest
, vol.20
, pp. 222-236
-
-
Kirkin, A.F.1
Dzhandzhugazyan, K.N.2
Zeuthen, J.3
-
2
-
-
0036813331
-
Cancer/testis antigens: An expanding family of targets for cancer immunotherapy
-
Scanlan MJ, Gure AO, Jungbluth AA et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. ImnumoI Rev 2002; 188: 22-32.
-
(2002)
ImnumoI Rev
, vol.188
, pp. 22-32
-
-
Scanlan, M.J.1
Gure, A.O.2
Jungbluth, A.A.3
-
3
-
-
3042522562
-
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease
-
Dhodapkar MV, Osman K, Teruya-Feldstein J et al. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer Immun 2003; 3: 9.
-
(2003)
Cancer Immun
, vol.3
, pp. 9
-
-
Dhodapkar, M.V.1
Osman, K.2
Teruya-Feldstein, J.3
-
4
-
-
0037320594
-
Cancer/testis tumour-associated antigens: Immunohistochemical detection with monoclonal antibodies
-
Juretic A, Spagnoli GC, Schultz-Thater E et al. Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies, Lancet Oncol 2003; 4: 104-9.
-
(2003)
Lancet Oncol
, vol.4
, pp. 104-109
-
-
Juretic, A.1
Spagnoli, G.C.2
Schultz-Thater, E.3
-
5
-
-
0029642252
-
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
-
Marchand M, Weynants P, Rankin E et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63: 883-5.
-
(1995)
Int J Cancer
, vol.63
, pp. 883-885
-
-
Marchand, M.1
Weynants, P.2
Rankin, E.3
-
7
-
-
0033405438
-
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
-
Thurner B, Haendle I, Roder C et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190: 1669-78.
-
(1999)
J Exp Med
, vol.190
, pp. 1669-1678
-
-
Thurner, B.1
Haendle, I.2
Roder, C.3
-
8
-
-
0034852872
-
Immune responses to tumour antigens: Implications for antigen specific immunotherapy of cancer
-
Jager D, Jager E, Knuth A. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J Clin Pathol 2001; 54: 669-74.
-
(2001)
J Clin Pathol
, vol.54
, pp. 669-674
-
-
Jager, D.1
Jager, E.2
Knuth, A.3
-
9
-
-
0033931860
-
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
-
Jungbluth AA, Stockert E, Chen YT et al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer 2000; 83: 493-7.
-
(2000)
Br J Cancer
, vol.83
, pp. 493-497
-
-
Jungbluth, A.A.1
Stockert, E.2
Chen, Y.T.3
-
10
-
-
0035876940
-
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
-
Jungbluth AA, Chen YT, Stockert E et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001; 92: 856-60.
-
(2001)
Int J Cancer
, vol.92
, pp. 856-860
-
-
Jungbluth, A.A.1
Chen, Y.T.2
Stockert, E.3
-
11
-
-
0035888172
-
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7
-
Jungbluth AA, Antonescu CR, Busam KJ et al. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer 2001; 94: 252-6.
-
(2001)
Int J Cancer
, vol.94
, pp. 252-256
-
-
Jungbluth, A.A.1
Antonescu, C.R.2
Busam, K.J.3
-
12
-
-
0037142182
-
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues
-
Jungbluth AA, Chen YT, Busam KJ et al. CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. Int J Cancer 2002; 99: 839-45.
-
(2002)
Int J Cancer
, vol.99
, pp. 839-845
-
-
Jungbluth, A.A.1
Chen, Y.T.2
Busam, K.J.3
-
13
-
-
0033994480
-
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters
-
Busam KJ, Iversen K, Berwick M et al. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Mod Pathol 2000; 13: 459-65.
-
(2000)
Mod Pathol
, vol.13
, pp. 459-465
-
-
Busam, K.J.1
Iversen, K.2
Berwick, M.3
-
14
-
-
0030699528
-
MAGE-3 immunoreactivity in formalin-fixed, paraffm-embedded primary and metastatic melanoma; frequency and distribution
-
Hofbauer GF, Schaefer C, Noppen C et al. MAGE-3 immunoreactivity in formalin-fixed, paraffm-embedded primary and metastatic melanoma; frequency and distribution. Am J Pathol 1997; 151: 1549-53.
-
(1997)
Am J Pathol
, vol.151
, pp. 1549-1553
-
-
Hofbauer, G.F.1
Schaefer, C.2
Noppen, C.3
-
15
-
-
85044700197
-
Expression of cancer-testis genes in human hepatocellular carcinomas
-
Luo G, Huang S, Xie X et al. Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immun 2002; 2: 11.
-
(2002)
Cancer Immun
, vol.2
, pp. 11
-
-
Luo, G.1
Huang, S.2
Xie, X.3
-
16
-
-
0037431558
-
Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-8
-
Bettinotti MP, Panelli MC, Ruppe E et al. Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-8. Int J Cancer 2003; 105: 210-6.
-
(2003)
Int J Cancer
, vol.105
, pp. 210-216
-
-
Bettinotti, M.P.1
Panelli, M.C.2
Ruppe, E.3
-
17
-
-
0021415167
-
Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, October 24-26, 1983
-
Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, October 24-26, 1983. J Am Acad Dermatol 1984; 10: 683-8.
-
(1984)
J Am Acad Dermatol
, vol.10
, pp. 683-688
-
-
-
18
-
-
0031755225
-
Simulators of malignant melanoma of the skin
-
Cerroni L, Kerl H. Simulators of malignant melanoma of the skin. Eur J Dermatol 1998; 8: 388-96.
-
(1998)
Eur J Dermatol
, vol.8
, pp. 388-396
-
-
Cerroni, L.1
Kerl, H.2
-
19
-
-
0033847898
-
Telomerase activity in melanocytic lesions: A potential marker of tumor biology
-
Rudolph P, Schubert C, Tamm S et al. Telomerase activity in melanocytic lesions: a potential marker of tumor biology. Am J Pathol 2000; 156: 1425-32.
-
(2000)
Am J Pathol
, vol.156
, pp. 1425-1432
-
-
Rudolph, P.1
Schubert, C.2
Tamm, S.3
-
20
-
-
0026322151
-
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
-
van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
-
(1991)
Science
, vol.254
, pp. 1643-1647
-
-
Van Der Bruggen, P.1
Traversari, C.2
Chomez, P.3
-
21
-
-
0028050181
-
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
-
De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360-9.
-
(1994)
Immunogenetics
, vol.40
, pp. 360-369
-
-
De Plaen, E.1
Arden, K.2
Traversari, C.3
-
22
-
-
0029069090
-
Identification and intracellular location of MAGE-3 gene product
-
Kocher T, Schultz-Thater E, Gudat F et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res 1995; 55: 2236-9.
-
(1995)
Cancer Res
, vol.55
, pp. 2236-2239
-
-
Kocher, T.1
Schultz-Thater, E.2
Gudat, F.3
-
23
-
-
0034062277
-
Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family
-
Rimoldi D, Salvi S, Schultz-Thater E et al. Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 2000; 86: 749-51.
-
(2000)
Int J Cancer
, vol.86
, pp. 749-751
-
-
Rimoldi, D.1
Salvi, S.2
Schultz-Thater, E.3
-
24
-
-
0034659682
-
Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4
-
Landry C, Brasseur F, Spagnoli GC et al. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 2000; 86: 835-41.
-
(2000)
Int J Cancer
, vol.86
, pp. 835-841
-
-
Landry, C.1
Brasseur, F.2
Spagnoli, G.C.3
-
25
-
-
0027999186
-
A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing
-
Becker JC, Gillitzer R, Brocker EB. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 1994; 58: 346-8.
-
(1994)
Int J Cancer
, vol.58
, pp. 346-348
-
-
Becker, J.C.1
Gillitzer, R.2
Brocker, E.B.3
-
26
-
-
0032578697
-
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies
-
Sahin U, Tureci O, Chen YT et al. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer 1998; 78: 387-9.
-
(1998)
Int J Cancer
, vol.78
, pp. 387-389
-
-
Sahin, U.1
Tureci, O.2
Chen, Y.T.3
-
27
-
-
0033168930
-
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
-
De Backer O, Arden KC, Boretti M et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999; 59: 3157-65.
-
(1999)
Cancer Res
, vol.59
, pp. 3157-3165
-
-
De Backer, O.1
Arden, K.C.2
Boretti, M.3
-
28
-
-
0036787389
-
Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma
-
Lohmann CM, Iversen K, Jungbluth AA et al. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am J Surg Pathol 2002; 26: 1351-7.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 1351-1357
-
-
Lohmann, C.M.1
Iversen, K.2
Jungbluth, A.A.3
-
29
-
-
0029796252
-
Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan
-
Pluschke G, Vanek M, Evans A et al. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc Natl Acad Sci USA 1996; 93: 9710-5.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 9710-9715
-
-
Pluschke, G.1
Vanek, M.2
Evans, A.3
-
30
-
-
0038660702
-
Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling
-
Epub 2003 Jan. 03
-
Govindarajan B, Bai X, Cohen C et al. Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J Biol Chem 2003; 278: 9790-5. Epub 2003 Jan. 03.
-
(2003)
J Biol Chem
, vol.278
, pp. 9790-9795
-
-
Govindarajan, B.1
Bai, X.2
Cohen, C.3
|